SUNLITSCI：ANNUALRESULTSANNOUNCEMENTFORTHEYEARENDED31DECEMBER2024ANDCHANGEINCOMPOSITIONOFTHENOMINATIONCOMMITTEE.pdf

《SUNLITSCI：ANNUALRESULTSANNOUNCEMENTFORTHEYEARENDED31DECEMBER2024ANDCHANGEINCOMPOSITIONOFTHENOMINATIONCOMMITTEE.pdf》由会员分享，可在线阅读，更多相关《SUNLITSCI：ANNUALRESULTSANNOUNCEMENTFORTHEYEARENDED31DECEMBER2024ANDCHANGEINCOMPOSITIONOFTHENOMINATIONCOMMITTEE.pdf（28页珍藏版）》请在三个皮匠报告上搜索。

1、 1 Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement,make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in rel

2、iance upon the whole or any part of the contents of this announcement.Wuxi Sunlit Science and Technology Company Limited*(A joint stock company established in the Peoples Republic of China with limited liability)(Stock Code:1289)無 錫 盛 力 達 科 技 股 份 有 限 公 司ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED

3、 31 DECEMBER 2024 AND CHANGE IN COMPOSITION OF THE NOMINATION COMMITTEEFinancial HighlightsFor the year ended 31 DecemberChange20242023Revenue(RMB million)516.0313.364.7%Gross profit(RMB million)143.2 95.949.3%Profit before income tax(RMB million)56.7 34.166.3%Profit for the year(RMB million)49.5 29

4、.368.9%Profit attributable to shareholders of the Company(RMB million)49.5 29.368.9%Basic and diluted earnings per share(RMB cents)38.70 22.9368.8%ANNUAL RESULTSThe board(the“Board”)of directors(the“Directors”)of 無錫盛力達科技股份有限公司(Wuxi Sunlit Science and Technology Company Limited*)(the“Company”or“Sunli

5、t”)is pleased to announce the audited consolidated financial results of the Company and its subsidiaries(collectively,the“Group”)for the year ended 31 December 2024(the“Year”).2 CONSOLIDATED INCOME STATEMENT(All amounts in RMB thousands unless otherwise stated)Year ended 31 DecemberNotes20242023Reve

6、nue3516,019313,265Cost of sales(372,806)(217,393)Gross profit143,21395,872Selling expenses(4,751)(2,773)Administrative expenses(55,584)(52,994)Net impairment losses of impairment losses on financial assets(40,673)(23,857)Other income10,2322,423Other gain net42,8719,392Operating profit/(loss)55,30828